Stereotaxis, Inc. (STXS) Stock Forecast & Price Target
Price as of Nov 17, 2026 close · Analyst estimates retrieved Nov 18, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)
Revenue and earnings estimates published by analysts covering Stereotaxis, Inc. (STXS), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.
For Stereotaxis, Inc., analysts forecast revenue rising from 29.37M in 2022 to 40.20M in 2027; the average estimate for 2027 earnings per share is −0.17; with published estimates ranging from −0.17 to −0.16; 4 analysts contribute to these figures. These are forecasts published by analysts, not results.
Analyst price targets
A price target is one analyst's forecast of where a share might trade, usually over twelve months. Targets are frequently revised, they disagree with each other, and they are not a measure of what a company is worth.
Revenue forecast (reporting currency)
The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.
Earnings per share forecast
Stereotaxis, Inc. (STXS) forecast — frequently asked questions
What is the analyst price target for Stereotaxis, Inc.?
Analysts covering Stereotaxis, Inc. (STXS) have a consensus price target of $3.50, 297.7% above the current price of $0.88. Published targets range from $3.50 to $3.50. A price target is a forecast, not a measure of value, and targets are revised often.
What are analysts forecasting for Stereotaxis, Inc.'s earnings?
The average analyst estimate for Stereotaxis, Inc. (STXS) earnings per share in 2027 is -0.17, with individual estimates between -0.17 and -0.16.
How much revenue is Stereotaxis, Inc. expected to make?
Analysts forecast Stereotaxis, Inc. (STXS) revenue of 40.20M in 2027, based on 2 published estimates.
How many analysts cover STXS?
4 analysts contribute estimates for Stereotaxis, Inc. (STXS). Thin coverage makes an average less reliable.
Analyst forecasts for other Medical - Instruments & Supplies stocks
Popular Stocks
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.